Abstract
<abstract><p>Anti-viral medication is comparably incredibly beneficial for individuals who are infected with numerous viruses. Mathematical modeling is crucial for comprehending the various relationships involving viruses, immune responses and health in general. This study concerns the implementation of a <italic>continuous</italic> Galerkin-Petrov time discretization scheme with mathematical models that consist of nonlinear ordinary differential equations for the hepatitis B virus, the Chen system and HIV infection. For the Galerkin scheme, we have two unknowns on each time interval which have to be computed by solving a $ 2 \times 2 $ block system. The proposed method is accurate to order 3 in the whole time interval and shows even super convergence of order 4 in the discrete time points. The study presents the accurate solutions achieved by means of the aforementioned schemes, presented numerically and graphically. Further, we implemented the classical fourth-order Runge-Kutta scheme accurately and performed various numerical tests for assessing the efficiency and computational cost (in terms of time) of the suggested schemes. The performances of the fourth order Runge-Kutta and the Galerkin-Petrov time discretization approaches for solving nonlinear ordinary differential equations were compared, with applications towards certain mathematical models in epidemiology. Several simulations were carried out with varying time step sizes, and the efficiency of the Galerkin and Runge Kutta schemes was evaluated at various time points. A detailed analysis of the outcomes obtained by the Galerkin scheme and the Runge-Kutta technique indicates that the results presented are in excellent agreement with each other despite having distinct computational costs in terms of time. It is observed that the Galerkin scheme is noticeably slower and requires more time in comparison to the Runge Kutta scheme. The numerical computations demonstrate that the Galerkin scheme provides highly precise solutions at relatively large time step sizes as compared to the Runge-Kutta scheme.</p></abstract>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.